AIR Global PLC (AIIR) Earnings Call Transcript & Summary
November 12, 2026
Earnings Call Speaker Segments
Gaurav Jain
executiveGood morning, everyone, and thanks for being on AIR Global PLC's call covering the third quarter and 9-month 2026 earnings. With me today are Stuart Brazier, our CEO, and Bassem Lotfy, our CFO. Once the prepared remarks are done, we'll open things up for your questions; our third quarter earnings press release came out this morning. You can find that release along with the accompanying materials on our Investor Relations website, ir.air.global, and also on the SEC's website, sec.gov. A replay of today's webcast in audio form will be posted later today. During today's discussion we'll be making forward-looking statements that reflect our current expectations and information; such statements carry risks and uncertainties, and many of those lie beyond the company's control. Except where the law requires it, AIR Global disclaims any duty to update forward-looking statements. We encourage you to review the safe harbor statements and risk factors included in today's press release and in our latest filings with the SEC, which provide additional information and describe risks that could cause actual results to differ materially from what our forward-looking statements contemplate. Results will be presented on both an IFRS and a non-IFRS basis. Our press release details non-IFRS measures, including adjusted EBITDA, together with their IFRS reconciliations. Non-IFRS financial measures should not be treated as a substitute for our results reported under IFRS. With that said, I'll hand things over to Stuart.
Stuart Brazier
executiveThanks, and hello everyone—glad you could join us today. Moving to Q3, revenue rose 11.1% to roughly $100 million, while adjusted EBITDA climbed 7.7% to about $31 million. FSM shipment volumes were up 5.8% after a 9% drop in the first half, with price and mix contributing another 5%. Shipments kept recovering from the supply chain disruption, and end-consumer demand stayed resilient; we are reaffirming guidance for 2026 and the medium term. Bassem will walk you through the financials in more detail shortly. Before that, I want to spend a few minutes on AIR's transformation and how we become the top specialist in social inhalation and modern nicotine experiences. Our core business is one of a kind. Through Al Fakher, we are number one worldwide in flavored shisha molasses; as of the end of 2024, our estimated global volume share across the markets we operate in stood at 36%-44%, and we hold very strong positions in key markets, including the United States, where our share is estimated at approximately 60%-65%. This category is shaped by social, cultural, and lifestyle factors. People enjoy it at home and in lounges, across generations and geographies, and it serves as more than just an occasion for nicotine delivery—which explains why shisha volumes have held up in recent years, unlike many traditional tobacco categories that saw substantial volume declines. Al Fakher has delivered modest volume growth in the US and globally since 2018. We estimate that about 14 million consumers worldwide use Al Fakher, putting it among the ten largest tobacco brands globally by consumer reach. Shisha remains a very affordable pleasure; in America, at-home shisha costs consumers around $110 yearly, far below cigarettes, pod-based vaping products, and nicotine pouches, whose annual consumer spend typically ranges between $400 and $2,200. From the consumer's perspective, a small increase in flavored shisha's retail price has only a modest effect on total spending. Yet for AIR, such pricing moves can provide substantial support for revenue growth and recovery from inflation. For the first nine months, price mix growth was 11.1%, which demonstrates both the strength of our brands and how affordable this category remains. And importantly, even with those pricing actions, we've held our market share—that gives us greater confidence in the business's long-term earnings growth potential. Now, on new growth categories, we're focused on our US-rechargeable pod-vape platform, Crown Switch. In early November, we filed our US premarket tobacco product application for Crown Switch. That application contains a substantial body of evidence, and submitting it marks an important milestone in our strategy to build a responsible, science-led presence in the regulated US vaping market. We believe Crown Switch could offer adult smokers a distinct alternative to combustible cigarettes, and we're eager for the FDA to review it. Notably, Greentank's quantum chip technology powers Crown Switch. Testing of the aerosol, a component of what went into our PMTA submission, showed that certain harmful and potentially harmful constituents registered at low levels or could not be detected when compared with other comparator products that have received FDA authorization, and in our view this reinforces the platform's differentiated profile. Through our strategic investment in Greentank, we have secured access to that technology, better commercial terms, and a long-term supply arrangement. With Al Fakher's reach, we gain an existing customer base and solid brand awareness as we get Crown Switch ready for launch in the US. We recognize that a strong brand on its own does not guarantee success—regulatory clearances, whether consumers pick it up, and how well we execute will decide how fast we can grow. A question investors often raise is why we put vapes ahead of pouches. There are three reasons. First, because we are smaller than the big multinational tobacco companies, we must concentrate our resources, and at present that means vapes come before nicotine pouches, since we have already had success in disposable vapes by licensing Al Fakher Crown Bar, which accounted for 4% of 2025 revenues. Also, we believe that in the near term, profitability trends for US vapes and pouches are moving in opposite directions. This reflects the crackdown on illicit vapes in the US, while pouches are facing intense competition. And third, while we believe the long-term economics of modern oral will be attractive once competition stabilizes, we intend to take part only when we have a differentiated product and a right to win—which we do not have today. Our investment objective is to produce attractive returns on invested capital across both FSM and new growth categories. We are not aiming to run an NGC business that adds to revenue but generates little or negative EBITDA in perpetuity. With that said, I'll now hand things to Bassem, who will walk us through the financial results for the third quarter and the nine-month period in more detail. With an estimated 36%-44% global volume share in the markets where we operate as of the end of 2024, and with very strong positions in key markets, including the United States, where our market share is estimated at approximately 60%-65%.
Bassem Lotfy
executiveThanks, Stuart, and hello everyone. I'll walk you through the results for the group and our segments, then the reconciliation from reported earnings to adjusted EBITDA, and finally net debt. Beginning with group performance, third quarter revenue was up 11.1%, reaching $100 million versus $90 million in the same period a year ago. Gross profit climbed 9.8% to $53 million, while adjusted EBITDA rose 7.7% to $31 million. Operating profit came in at $18 million, compared with $17 million last year. Profit for the period grew to $8 million from $7 million, and basic EPS was $0.05. Higher logistics, material, and factory footprint costs continued to pressure margins during the quarter. Gross margin stood at 53.3% versus 54% a year earlier. Adjusted EBITDA margin was 31%, compared with 31.9% in Q3 2025. On supply chain and costs, after the Strait of Hormuz closed, we set up alternative routes, and shipments resumed as those routes came into operation. Elevated energy, shipping, insurance, security, and raw material costs tied to the Middle East conflict are hitting our industry, and AIR is no exception. We anticipate that this extended stretch of elevated costs will cause modest margin compression in 2026; we're offsetting it through alternative routes, pricing actions, and an accelerated reorganization of our factory footprint, and our Romania facility is still on schedule to open in the first quarter of 2027, which will further diversify where we manufacture. If and when costs like shipping return to normal, which we believe they should based on historical patterns, we would expect AIR to capture most of the savings. Until that happens, protecting supply and keeping products available for consumers is our priority. Over the first 9 months, revenue rose 6% to $307 million, gross profit was up 4.6% to $170 million, and adjusted EBITDA grew 2.3% to $103 million. Adjusted EBITDA margin came in at 33.5%, compared with 34.7% in the prior year period. FSM shipment volumes grew 5.8% in the third quarter, while price and mix rose 5%. For the first 9 months, shipment volumes fell 4.6%, reflecting the disruption in the first half, while price and mix were up 11.1%. Moving to our segments, Americas revenue rose 25.6% to $22 million in the third quarter. Adjusted EBITDA fell 3.6% to $8 million, largely on higher costs of goods sold. Over the first 9 months, revenue grew 10% and adjusted EBITDA was up 10.5%. In MEA, third quarter revenue increased 9.4% to $64 million, and adjusted EBITDA rose 2.4% to $25 million. For the first 9 months, revenue grew 5.7%, while adjusted EBITDA declined 2.2%. MEA includes our corporate headquarters, so its results reflect higher ongoing public company costs along with supply chain and material cost pressures. Europe's third quarter revenue grew 4.9% to $14 million. Adjusted EBITDA was $1 million, compared with roughly breakeven last year. Over the first 9 months, revenue grew 2.1%, while adjusted EBITDA fell to $1 million from $2 million. In new growth categories, third quarter revenue was slightly negative, reflecting the timing of trade incentives. Adjusted EBITDA loss improved to $3 million, compared with $4 million before. Across the first 9 months, that loss shrank to $11 million from $13 million, driven by reduced operating costs and a sharper concentration of investment behind new product launches. Now I'll walk through the key adjustments bridging our reported loss and adjusted EBITDA for the first 9 months. We acknowledge that results for 2026 year-to-date contain several one-off items. AIR drafts its financial statements under IFRS as issued by the IASB, and being Nasdaq-listed, it complies with SEC rules on non-IFRS measures. Our aim is to show adjusted figures that, in our view, capture more accurately the underlying operating performance of the business. During the first 9 months, the reported loss for the period came to $74 million, while adjusted EBITDA stood at $103 million. The biggest adjustments stem from our listing, which wrapped up on Nasdaq in May 2026. Those adjustments comprise $48 million of non-cash expense tied to equity issued as part of the business combination, $48 million in transaction fees, $14 million of share-based compensation, and $10 million of public company readiness costs. Further adjustments take in $4 million of supply chain-related costs stemming from the Strait of Hormuz disruption plus $3 million of regulatory costs connected to preparing and submitting our US PMTA, which we view as infrequent and non-recurring against our normal operating activities. The non-cash equity issuance expense, transaction fees, and public company readiness costs jointly make up $106 million of listing-related adjustments. Such items do not represent the business's capacity for recurring earnings. We disclose adjusted EBITDA so investors can gauge our underlying operating performance apart from items that are non-cash, tied to the listing, or unlikely to recur on a regular basis. Adjusted EBITDA does not replace IFRS results or cash flow. Investors ought to weigh both measures together with cash generation, leverage, and the anticipated drop in exceptional costs as AIR moves past its listing and refinancing activity. Shifting to cash flow and the balance sheet, total borrowings, meaning current plus non-current borrowings and including lease liabilities, reached $404 million at September 30. Cash and cash equivalents totaled $39 million, leaving net debt of $365 million. Rolling 12-month adjusted EBITDA came in at $142 million, which puts net debt to adjusted EBITDA at 2.6 times; in short, the third quarter brought a recovery in operating performance, with double-digit revenue growth and high single-digit adjusted EBITDA growth even as cost pressure persisted. Our attention now goes to strengthening cash conversion, bringing leverage down, and delivering disciplined shareholder returns. With that, I'll return the floor to Stuart.
Stuart Brazier
executiveThank you, Bas. I'll move on now to how our capital is structured and what we return to shareholders. Since the results for our first half, we've made the capital structure stronger and laid out a more transparent plan for giving cash back to shareholders; on October the 1st, we issued $425 million in senior unsecured notes carrying a coupon of 7.875%, maturing in 2031. Those proceeds went toward refinancing our existing term loan and paying down the outstanding revolving credit facility, and that widens our access to capital, stretches out our debt maturity profile, and gives us more financial flexibility. Pending board approval, we also plan to start an annual dividend of $0.28 per share, paid in quarterly installments, beginning with our first quarter 2027 results, and to keep a progressive dividend policy in place after that. We expect to fund shareholder returns out of equity free cash flow, which is how we define cash flow from operations minus capital expenditure, interest expense, and principal and interest payments on lease liabilities. Beyond that, we're setting up a repurchase program that would let us buy back as much as $100 million of shares through December 2029, depending on market conditions, capital requirements, and applicable approvals. Our framework for allocating capital balances three priorities: investing in high-return growth, keeping leverage prudent, and returning capital to shareholders. Taking into account dividends and share repurchases, we expect net debt to adjusted EBITDA to fall to 2 times or below by December 2027; moving now to guidance, we are reiterating our operating outlook for full-year 2026; we still expect shipment volumes that are broadly stable against 2025, revenue growth of 4 to 6% in US dollars, and adjusted EBITDA growth in the low to mid single digits. One item worth flagging is leverage. We now expect year-end net debt to adjusted EBITDA of roughly 2.5 times, versus 2.1 times previously; that mirrors bond issuance and refinancing cash flows along with temporary working capital timing stemming from the supply chain disruption, which we expect to normalize during 2027; we now expect full-year capital expenditure of $11 million to $14 million, versus $15 million to $18 million previously. Our expected effective tax rate is still approximately 15%. Our operating framework for 2027 and the medium term is unchanged: low single-digit organic FSM shipment volume growth, mid single-digit FSM revenue growth, and high single-digit FSM adjusted EBITDA growth, assuming non-disruptive excise tax increases. I'll finish with three messages. First, we lead our category in a high-margin business with resilient consumer demand, and both our 2026 operating outlook and our medium-term operating framework are unchanged. Second, we've strengthened our capital structure and set out a clear approach to shareholder returns, with leverage expected to fall to 2 times or below by December 2027. Third, we hold a disciplined option on future growth. We have submitted the Crown Switch PMTA, and we will invest selectively in new growth categories, with a focus on generating attractive returns on capital. With category leadership, robust cash generation, several growth drivers, and an anticipated deleveraging, AIR brings together qualities that we think leave the business well placed to create value sustainably and deliver appealing returns to shareholders over the long term. Thanks for being with us today, and we'll move now to your questions.
Nick Anderson
analystAppreciate you taking my questions, and congrats on the quarter. First thing from me: on the volume recovery, what portion comes from distributors restocking versus real consumer demand? And where do channel inventories sit right now compared with normal levels? A regional breakdown would be really useful. Thank you.
Stuart Brazier
executiveHi, Nick. Thanks for asking. As you can see, in the third quarter we essentially clawed back half of the volume shortfall we carried in the first half, and our guidance is for volumes to be flat for the year. We anticipate additional recovery arriving over the final 3 months. On the inventory side, if we look at raw materials, levels are elevated at the plants right now because of the uncertainty in certain supply chains. Where previously we may have relied on a single dependable channel for inbound raw materials, today we have to bring them in through several channels. On top of that, we've shifted US production into our Poland facility, and that has meant accumulating larger raw material inventories there as well. That gives you a rough picture of the current market situation. Broadly speaking, demand has held up well; in a typical year, our mid-term guidance calls for low single-digit volume growth. For this year, we anticipate volumes will be flat, driven by a headwind in global travel retail—our duty free operation, primarily at Middle East airports, which took a significant hit during the first half, though we are now seeing that recovery materialize in H2.
Gaurav Jain
executiveLet me add something there, Nick. It's clear that through 9 months our volumes are down 4.6%, and for the full year we're saying volumes are flat, though obviously end-consumer demand doesn't swing around like that. There's some inventory replenishment tied to what you were asking about. At this point the gap is quite small; by the end of this year we aren't seeing inventories that are either in excess or below end demand.
Nick Anderson
analystGreat, I appreciate that color. For my second question, on Greentank — you have the option to put more investment in there. What regulatory or commercial catalyst would you be looking for to exercise that option? And how does that stack up against putting capital toward share repurchases or other investment opportunities? Thank you.
Stuart Brazier
executiveWith Greentank, we hold that option, or warrant. Our view is that the product is differentiated. We see it as relevant to us, and we also see it as potentially relevant to the industry. That's the reason we have the warrant; we have just submitted the PMTA. For us, the next milestone is seeking FDA acceptance of that submission for scientific review. That would allow us to start promoting and selling the item across the US. Clearly, if we managed that, there would obviously be more advantage and worth in using that warrant; those are the sorts of developments we need to monitor, Nick, prior to making that choice. Of course, if Crown Switch wins consumer acceptance and begins delivering strong results, then exercising would be a very sensible move on our part.
Nick Anderson
analystAll right, that's all from my side. I'll hand it over. Congratulations once more on the quarter.
Stuart Brazier
executiveThanks.
Morayo Adesina
analystHello, team, and thank you so much for taking my question. I have a few. On leverage, which obviously is expected to come in somewhat higher by the end of 2026, could you break down the increase between the costs tied to the bond and the working capital movements? And then how should we think about working capital normalizing next year when it comes to timing? How should we think about the split between the two halves? That is the first one; and my second question is on cost pressures, when do you sort of expect those to normalize? How should we think about pricing in Q4 and then as we head into next year?
Stuart Brazier
executiveYeah. Perhaps I'll take that last one first. Obviously, it is quite hard to predict when things will normalize or stabilize in the Middle East. History always tells us that over time, things do normalize. We've taken pricing this year, and we will take pricing next year as well to make sure that we are passing this cost inflation on to the consumers. When things do normalize, then obviously, we will have the benefit of higher margins. As for how working capital works in general for the business, historically, the first half of the year has always been a little more working capital intensive than the second half of the year, and that has historically been reflected in the cash flows.
Bassem Lotfy
executiveLooking at leverage at the close of the 9 months, higher stocks had an effect, and we anticipate part of that reversing by year-end; that is the reason our guidance points to a ratio of 2.5. The figure has risen compared with earlier guidance, largely due to cash costs tied to the bond issuance, and we expect a small amount of working capital impact from the disruption to still be present at year-end. We anticipate those effects reversing as we move forward.
Gaurav Jain
executiveOn the specific figures you were asking about, Morayo, here is what we can tell you: looking at the overall rise in leverage we have described, roughly 1/3 comes from refinancing the debt, while 2/3 comes from the higher working capital. The reason is simply that the disruption is lasting longer than what was expected back in August. Over time it should unwind, and that is why we are saying leverage will be below 2x at the end of next year.
Morayo Adesina
analystGreat, thanks. That's useful. Just a quick follow-up about Europe.
Stuart Brazier
executiveI'd already stepped out.
Morayo Adesina
analystOh, sorry — carry on.
Stuart Brazier
executiveYeah, no, I was only going to add that, clearly, the Romanian factory commissioning is in place. That Romanian factory goes live in Q1 of next year, and that lowers the risk on the factory footprint over the longer term too.
Morayo Adesina
analystGreat, thanks — that helps. And then a quick follow-up on Europe: I recall that back at H1 you mentioned expecting part of those delayed shipments to catch up over Q3 and Q4. I'm just curious how much of that catch-up actually happened in Q3, and how much is still left for Q4?
Stuart Brazier
executiveWe did see volume recovery in Q3. However, mix in Europe has not been positive. Business in Europe is pretty difficult right now. Disposable incomes are squeezed. As I mentioned, volume recovery has come through, but the geographic mix has watered down the effect on the top line. You'll also have picked up that Germany announced an excise increase, which will be? implemented starting the 1st of March next year; it's lower than it might have been, but it still represents a step up from where we are today. The major difficulty across European markets is, naturally, that when excise goes up, that obviously has to be passed on to the consumer, and if authorities aren't stamping out illicit trade, that can pose a genuine risk to the legal market in the EU. For Q4, we still expect to see good volumes, but looking further into the mid-term, we see the US as having been a key driver of our business, with our Middle East, Africa, and Asia region next, and Europe likely the weakest of our three regions where growth is concerned.
Morayo Adesina
analystGreat, thanks. That helps. I'll relay it.
Kato Mukuru
analystHi there. Are you perhaps referring to Kato Mukuru? Hello?
Gaurav Jain
executiveHi, Kato. Yeah, I believe the operator likely got your name wrong, but go right ahead. < >
Kato Mukuru
analystThat wasn't even close. So, two questions from me. Regarding the $100 million share repurchase program you have running through December 2029, could you remind me what the cap is for any given single year, say this year? Is it 25 million annually through 2029? And then on margins, I get the cost pressures from the disruption in Abu Dhabi. Once that normalizes, how much margin recovery do you think we could see by the time we're 2 or 3 years out? Because I still believe it could be meaningful, since you have considerable cost flexibility once everything settles. Just give us a sense of how much higher on an EBITDA margin basis, or gross margin basis, whichever is easier for you. I just want to get a feel for how much wider it can get. Thanks.
Stuart Brazier
executiveYeah, sure. On your last point, if you're projecting forward and costs start to normalize, then at the gross margin level, I think you can probably expect roughly 300 300 basis points of improvement over time. There's certainly some potential for great benefit once things do normalize. Your first question was on the share buyback. There isn't any sort of set year-by-year plan for what we'll do. We're constrained by how much we can do, and that depends on trading volume. We can repurchase up to 20% of the weighted average daily volume for the prior 30 30 days, right? That resets every Friday. Obviously, we'll decide when it's appropriate for shareholders and for the business to exercise the repurchase.
Gaurav Jain
executiveIf I could add to that, Kato, look, this is a business model driven by pricing, and when you examine our bigger peers and strip out just their core operations, you'll notice that margins, over quite a lengthy stretch, keep on widening. There's no theoretical ceiling on how high margins can climb, and the same holds for us, and really it comes down to the spread between the price per kilo and the cost per kilo at which we sell. Stuart's remark about 300 basis point gross margin expansion is really more of a medium-term statement rather than representing the terminal kind of potential for how high margins in that business can go. Naturally, there's leverage on the operating cost side too. When you look at our medium-term guidance, where we state that revenue growth is 4 to 6% on FSM and EBITDA growth is high single-digit, then basically you're looking at 50 to 100 basis point of adjusted EBITDA margin expansion year-on-year, and if we're recovering from a depressed margin base, then in any single year, the expansion could be larger. Those factors will need to be kept in mind.
Kato Mukuru
analystGreat. Thanks a lot.
Gerald Pascarelli
analystHi, everyone. Many thanks for that question. I actually had a couple of things here, but staying with the PMTA we filed for Crown Switch, I'd really like to hear your wider perspective on the US vape market overall. Some headway has been made when it comes to reining in the illicit market. I realize approval is needed and certain steps have to take place before any rollout, but in an ideal scenario, what would you need to see, or what changes would have to occur in the US market, for you to feel more constructive about eventually launching there? Thank you.
Stuart Brazier
executiveI believe I noted earlier that in the US, the pod-based vape market strikes us as our biggest opportunity. Several reasons sit behind that. First, we see the FDA, the authorities, treating this more seriously when it comes to genuinely stamping out or cutting back the illicit vape market, and clearly that's a terrific opening for the legal market to expand. Second, they've become a bit more flexible on flavors now, and a number of submissions have gone in to them that will permit more flavors than just the tobacco and menthol they've historically allowed. Third, the largest player in the US is seeing profitability on their platform that is actually very, very strong. I'll have Gaurav cover that in a little more detail shortly. If you set that against what's actually going on in the nicotine pouches segment, where competition has ramped up and we're starting to see margins squeezed as pricing becomes increasingly aggressive. We're really enthusiastic about the prospect of having a differentiated product in what we think will be a more profitable and more valuable segment going forward. On timing, we stated we would file the PMTA this year, and we've now completed that. When I spoke about it before, I said it might be 6 months until we receive the next approval, which would mean the PMTA moves into scientific review, and at that stage we can begin selling. It might come sooner than that, but we'll simply have to wait and see, Gerald. Gaurav, perhaps you could say a bit more about
Gaurav Jain
executiveMorning, Gerald. Look, I'd say the vape sector both in America and around the world is intensely competitive, and a substantial chunk of it is plainly illicit product. Regulators do seem to be getting tougher on that, both in the US and in other parts of the world. Step into any shop and you'll still plainly spot plenty of items you'd describe as unauthorized. That aspect of the market is real, yet a crackdown is underway. If you look at how many established big players are bringing vapes to the US market, or new entrants for that matter, that number is actually far smaller than what you're seeing in the pouch category. That's precisely why some of our peers, including the biggest ones, have stated that although end market growth in consumer spend terms might land in the low to mid single-digit range, the manufacturer revenue pool could compound at mid-teens across the coming few years as the market shifts from illicit to legal. We share that view, going by our own figures. To us, that's a highly attractive growth market, and as you can see we're a very small company compared with the larger players. For us, even tiny market shares, provided they're profitable shares, will make a big difference. That's the way we're approaching the US vape market, building a meaningful business for us that is profitable and creates an impact.
Gerald Pascarelli
analystPerfect. Understood. That color is quite useful. I just had what I suppose is a housekeeping question about EBITDA. You posted a really solid recovery. With the 3Q performance, it's roughly in line with your longer-term targets. I realize revenue growth was quite strong, and that plays a part. Your full-year guidance does suggest a fairly wide range once fourth quarter performance is factored in. Could you maybe just discuss what supports the low end versus the high end of that range, or any particular considerations we should keep in mind as we model this out; and then, I suppose, more broadly, given that there are some one-off costs this year and some higher costs since you became a public company, I'm just trying to get a better sense of whether you believe we're reaching a point where your EBITDA should line up more closely with the longer-term targets you've set out. Thank you.
Stuart Brazier
executiveRegarding that last comment, Gerald, I think we'll see more of that in 2027. Certainly, a lot is flowing through the P&L this year, given everything we've achieved and also given some of the disruption we've experienced. In 2027, we'll see a much cleaner set of numbers.
Gaurav Jain
executiveOn the guidance front, Gerald, look, as you can well imagine and as you’re seeing in the headlines, the macro picture remains uncertain, so we’re simply choosing to stay prudent in case something happens. Beyond that, I don’t believe there’s anything else. There can always be some inventory movement toward year-end depending on how people view next year, but you’re correct that this year the Q4 range is wider than would typically be the case, and that’s purely so we can deal with anything should anything adverse occur on the macro side.
Stuart Brazier
executiveSince we’re mostly a B2B business and because there are still big volumes coming out of the UAE even now, I think we chose to keep the range wide so we’re somewhat protected if something occurs in the final 6 or 7 weeks of the year that could prevent us from getting certain shipments out, Gerald. I wouldn’t take anything beyond that from it.
Gerald Pascarelli
analystGreat, I appreciate the detail there. I will share that with the team.
Stuart Brazier
executiveThanks.
Operator
operatorThat brings our question and answer session to a close. Ladies and gentlemen, we appreciate your participation. Today's teleconference ends here. Kindly disconnect your lines, and have a wonderful day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete AIR Global PLC transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to AIR Global PLC earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in AIR Global PLC or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.